Discovering 4-6 Times More Undiagnosed & Miscoded Patients for Screening
Venue: McCormick Place, Chicago, IL, USA
The results of our collaboration with leading oncologists, titled “AI to characterize patients with lung or ovarian cancer and those with cachexia for discovery of undiagnosed, misdiagnosed, and miscoded patients at scale in a privacy-preserving manner” will be presented at the annual American Society of Clinical Oncology (ASCO) annual meeting.
Please let us know if you are available to meet by registering through the link below or emailing us at info@www.pangaeadata.ai